Arca
Skip to content
Tools
Tools

SpyGlass DS Direct Visualization System

Choledochoscope And Accessories, Flexible/Rigid. 510(k) K142922, from Boston Scientific Corporation (Marlboro, MA). Product code FBN, class 2.

As of Nov 18, 2026, K142922 is an FDA 510(k) held by Boston Scientific Corporation, substantially equivalent on Jan 16, 2015 after 100 days, with 1 recall tied to it in FDA's recall database.

  • Substantially equivalent: Jan 16, 2015
  • Review time: 100 days
  • Recalls: 1
  • Cited as a predicate by: 4 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The SpyGlass DS Direct Visualization System is indicated for use in diagnostic and therapeutic applications during endoscopic procedures in the pancreatico-biliary system including the hepatic ducts. The SpyGlass DS Direct Visualization System comprises two components: the SpyScope DS Access and Delivery Catheter and the SpyGlass DS Digital Controller.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

4 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K142922, newest first; each opens FDA's recall record
StartedReasonStatus
Dec 20, 2017Z-1133-2018Certain lots of devices may have the working channel sleeve protruding from the camera cap which may result in injuries from minor tissue damage to significant bleeding.Terminated

Other FBN Clearances

The newest 510(k)s for the same product code; their median review was 175 days; see every FBN device

Record

Type
Traditional
Received
Oct 8, 2014
Review panel
Gastroenterology, Urology
Regulation
21 CFR 876.1500

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.